Growth Metrics

Edwards Lifesciences (EW) Liabilities from Discontinued Operations (2023 - 2025)

Edwards Lifesciences has reported Liabilities from Discontinued Operations over the past 3 years, most recently at 200000.0 for Q3 2025.

  • For Q3 2025, Liabilities from Discontinued Operations fell 88.89% year-over-year to 200000.0; the TTM value through Sep 2025 reached 200000.0, down 88.89%, while the annual FY2024 figure was 2000000.0, 92.03% down from the prior year.
  • Liabilities from Discontinued Operations for Q3 2025 was 200000.0 at Edwards Lifesciences, down from 2300000.0 in the prior quarter.
  • Over five years, Liabilities from Discontinued Operations peaked at 30000000.0 in Q2 2024 and troughed at 200000.0 in Q3 2025.
  • A 3-year average of 9100000.0 and a median of 2300000.0 in 2025 define the central range for Liabilities from Discontinued Operations.
  • On a YoY basis, Liabilities from Discontinued Operations climbed as much as 88.89% in 2025 and fell as far as 92.33% in 2025.
  • Year by year, Liabilities from Discontinued Operations stood at 25100000.0 in 2023, then crashed by 92.03% to 2000000.0 in 2024, then tumbled by 90.0% to 200000.0 in 2025.
  • Business Quant data shows Liabilities from Discontinued Operations for EW at 200000.0 in Q3 2025, 2300000.0 in Q2 2025, and 2300000.0 in Q1 2025.